Who knows why different people have different symptoms with the common cold? Well, a new study used laboratory-grown noses ...

Li-Fraumeni syndrome is a rare hereditary disease that significantly increases the risk of developing cancer. Almost all ...

Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...

Scientists have described a novel, yet benign bone-covered growth's characteristics for doctors, so patients don't receive ...

New technology is allowing highly-trained surgeons to make smaller incisions, meaning less narcotics and fewer infections and ...

Agenus Inc. ("Agenus") , a leader in immuno-oncology, today announced it will host its first Stakeholder Webcast of 2026, Access to Acceleration: Agenus' Global Momentum Entering 2026 on Wednesday, ...

Cancer is a leading cause of death in both humans and pets; studies suggest that between one-third and one-half of all dogs ...

Cancer is a leading cause of death in both humans and pets; studies suggest that between one-third and one-half of all dogs will develop cancer during their lifetime. Hemangiosarcoma, an aggressive, ...

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964 (25)00509-2/fullte ...

Strasbourg, France, January 23, 2026, 8:00 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced ...

Agenus Inc. , a leader in immuno-oncology innovation, today announced the expansion of its global Medical Affairs infrastructure and early-access support capabilities in response to increasing ...